Ali E. Yesilkanal
Bristol-Myers Squibb (Germany)(DE)University of Chicago(US)Bristol-Myers Squibb (Belgium)(BE)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Cancer Mechanisms and Therapy, RNA modifications and cancer, Synthesis and biological activity, Epigenetics and DNA Methylation
Most-Cited Works
- → Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism(2019)407 cited
- → Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy(2013)225 cited
- → TET1-Mediated Hydroxymethylation Facilitates Hypoxic Gene Induction in Neuroblastoma(2014)170 cited
- → Raf Kinase Inhibitory Protein (RKIP) as a Metastasis Suppressor: Regulation of Signaling Networks in Cancer(2014)72 cited
- → Alterations of 5-Hydroxymethylcytosine in Human Cancers(2013)53 cited
- → New strategies for targeting kinase networks in cancer(2021)52 cited
- → Targeting Raf Kinase Inhibitory Protein Regulation and Function